Accuray Inc (ARAY) stock
Close on Nov 11, 2026Market cap $382.21MP/E –Yield –
Accuray Inc saw revenue fall 12.5% to $394.53M over the twelve months to Sep 30, 2026. Free cash flow was -$27.05M, down 256.6% from a year earlier. At the latest close the market valued the company at $382.21M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $382.21M
- P/E ratio
- –
- Price to sales
- 0.97
- Price to book
- 7.20
- Dividend yield
- –
- Free cash flow yield
- -7.08%
Fundamentals
- Revenue
- $394.53M
- Net income
- -$17.38M
- Free cash flow
- -$27.05M
- Book value per share
- $0.38
- Diluted shares
- 139M
Trading
- Next earnings
- Feb 3, 2027 (estimated, after the close)
- Previous close
- $3.19
- Open
- $3.28
- Day's range
- $3.10 – $3.40
- Volume
- 90,299
- Average volume (20 days)
- 463,651
- Index membership
- Russell 2000 (since Jun 2023), Russell 3000 (since Aug 2023)
- Beta (5 years)
- 0.87
- 52-week range
- $0.14 – $47.60
- RSI (14 days)
- 47.7
- Volatility (1 year)
- 23469.5%
- Relative volume
- 0.08×
- WACC
- 9.8%
Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2010, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | ARAY | S&P 500 | Difference | ARAY per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -65.2% | -2.4% | −62.8 pts | ||
| 3 months | -72.4% | -1.2% | −71.2 pts | ||
| Year to date | +288.1% | +12.3% | +275.8 pts | ||
| 1 year | -93.2% | +12.4% | −105.6 pts | ||
| 3 years | -96.8% | +78.8% | −175.6 pts | -68.1% | +21.4% |
| 5 years | -98.6% | +75.2% | −173.8 pts | -57.5% | +11.9% |
| 10 years | -98.5% | +311.1% | −409.6 pts | -34.3% | +15.2% |
Fifteen years at a glance
Fiscal years 2012 to 2026 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Accuray filed with the SEC as exhibits to Form 8-K or 6-K
- News
- Results
- Results
- News
- Results
- Results
About Accuray
Surgical & Medical Instruments & Apparatus
Accuray Incorporated develops, manufactures, sells, and supports radiation therapy solutions, including treatment delivery, planning, imaging, and data management systems. Its core offerings feature the CyberKnife robotic platform and helical systems such as Accuray Stellar, Radixact, Accuray Helix, and Tomo C. The company also provides integrated software solutions, such as the Accuray Precision Treatment Planning System and iDMS Data Management System, alongside professional services like customer support, installation, and training. Accuray serves clinicians, hospitals, cancer centers, and healthcare providers, with its equipment utilized by radiation oncologists and neurosurgeons to treat cancerous and benign tumors and selected functional disorders.
Company profile, executives and historyAccuray stock: common questions
What is Accuray's stock price?
ARAY closed at $3.20 on Nov 11, 2026, up 0.31% on the day. Over the past 52 weeks it traded between $0.14 and $47.60.
What is Accuray's market cap?
Accuray was worth $382.21M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
How much revenue does Accuray make?
Accuray reported revenue of $394.53M for the twelve months to Sep 30, 2026, down 12.5% from a year earlier.
Does Accuray pay a dividend?
No. Accuray has not paid a cash dividend over the last twelve months.
When does Accuray report earnings next?
Accuray is expected to report Q2 FY2027 results on Feb 3, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has ARAY stock performed over the past year?
Including dividends, ARAY returned -93.2% over the past year, against +12.4% for the S&P 500.
How many ARAY shares are sold short?
6M shares were sold short at the latest FINRA report, 6.58% of the float, or 2.9 days of average trading volume.
Who are Accuray's competitors?
Companies most similar to Accuray by business, industry and size include PRCT, NVCR, ANGO, LMAT, TCMD.
See a number that looks wrong?